Second, although we found that manipulating PDGF-BB expression in preosteoclast is sufficient to modulate neuroinflammation and nonspecific transcytosis, whether the specific knockdown of ALPL in brain endothelial cells can be waived due to the impairment of HFD-induced metabolic syndrome needs to be further investigated. Here, ALPL is linked to metabolic syndrome.